Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Meera Patrawala"'
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 23, Iss , Pp - (2020)
Pegvaliase (Palynziq®) was FDA approved in 2018 as an enzyme substitution therapy in patients with Phenylketonuria. However, various drug induced hypersensitivity adverse events (HAEs) have been reported. We present a case of Pegvaliase (Palynziq®)
Externí odkaz:
https://doaj.org/article/31a9996f8aee49c5a6c62a3fc788f4b9
Publikováno v:
Journal of Food Allergy. 2:124-127
Historically, the role of the health-care provider in medical practice has been primarily paternalistic by offering information, compassion, and decisive views with regard to medical decisions. This approach would exclude patients in the decision-mak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fff69f716fb8d381f9a71f9f0fe918db
https://doi.org/10.2500/jfa.2020.2.200009
https://doi.org/10.2500/jfa.2020.2.200009
Autor:
Elizabeth Garabedian, Ying Cui, Ramsay L. Fuleihan, Meera Patrawala, Lokesh Guglani, Limin Peng, Kiran Patel
Publikováno v:
Journal of Clinical Immunology. 40:340-349
Pulmonary manifestations are common in patients with primary immunodeficiency disorders (PIDs) but the prevalence, specific diseases, and their patterns are not well characterized. We conducted a retrospective analysis of pulmonary diseases reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b42fc9a76927ed6565373c0341d475d
https://doi.org/10.1007/s10875-019-00738-w
https://doi.org/10.1007/s10875-019-00738-w
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports
Pegvaliase (Palynziq®) was FDA approved in 2018 as an enzyme substitution therapy in patients with Phenylketonuria. However, various drug induced hypersensitivity adverse events (HAEs) have been reported. We present a case of Pegvaliase (Palynziq®)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e76b9f9c98f130d0fb4b56e35614c5f
http://www.sciencedirect.com/science/article/pii/S2214426920300215
http://www.sciencedirect.com/science/article/pii/S2214426920300215
Publikováno v:
Current Allergy and Asthma Reports. 20
There has been an explosion of monoclonal antibodies in the treatment of severe uncontrolled adult asthma. Studies have now been published in severe pediatric asthma. There are numerous questions that need to be answered in determining whether these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c367aaaa291e259adf48143f02538be
https://doi.org/10.1007/s11882-020-00919-3
https://doi.org/10.1007/s11882-020-00919-3
Publikováno v:
Current Allergy and Asthma Reports
Purpose of the Review Peanut oral immunotherapy (OIT) is one of the most studied experimental therapies for food allergy. With the recently FDA-approved peanut product, Palforzia, the goal of this article is to review the most recent data from clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c6c99eff3a25a45ec538465a71b8c8
https://pubmed.ncbi.nlm.nih.gov/32314071
https://pubmed.ncbi.nlm.nih.gov/32314071
Autor:
Lisa Kobrynski, Meera Patrawala
Publikováno v:
Current opinion in allergy and clinical immunology. 19(6)
PURPOSE OF REVIEW Although severe combined immunodeficiency (SCID) is the primary target condition for newborn screening (NBS), over 25 secondary targets, conditions other than SCID, have been identified. There is no standard method for evaluating ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e692aa86da800271c29ec1e2d2a8fc9
https://pubmed.ncbi.nlm.nih.gov/31490207
https://pubmed.ncbi.nlm.nih.gov/31490207
Publikováno v:
Ann Allergy Asthma Immunol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e046e8e09b1b78b7a935dc123612dea
https://pubmed.ncbi.nlm.nih.gov/30953786
https://pubmed.ncbi.nlm.nih.gov/30953786
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd8dfb6c0a34935d2f1a9a37614f5135
https://doi.org/10.1016/j.jaci.2019.12.188
https://doi.org/10.1016/j.jaci.2019.12.188
Publikováno v:
Annals of Allergy, Asthma & Immunology. 122:649-650
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da16283cc76c6ac9cba9ac48d865f60e
https://doi.org/10.1016/j.anai.2019.03.031
https://doi.org/10.1016/j.anai.2019.03.031